These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

626 related articles for article (PubMed ID: 17699370)

  • 41. Planning a cluster randomized controlled trial: methodological issues.
    Christie J; O'Halloran P; Stevenson M
    Nurs Res; 2009; 58(2):128-34. PubMed ID: 19289934
    [TBL] [Abstract][Full Text] [Related]  

  • 42. From randomized trials to registry studies: translating data into clinical information.
    Brown ML; Gersh BJ; Holmes DR; Bailey KR; Sundt TM
    Nat Clin Pract Cardiovasc Med; 2008 Oct; 5(10):613-20. PubMed ID: 18679381
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Statistical significance versus clinical relevance in cardiovascular medicine.
    Willenheimer R
    Prog Cardiovasc Dis; 2001; 44(3):155-67. PubMed ID: 11727275
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Improving the effectiveness of interventions in palliative care: the potential role of qualitative research in enhancing evidence from randomized controlled trials.
    Flemming K; Adamson J; Atkin K
    Palliat Med; 2008 Mar; 22(2):123-31. PubMed ID: 18372377
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Monitoring and reporting of the Women's Health Initiative randomized hormone therapy trials.
    Anderson GL; Kooperberg C; Geller N; Rossouw JE; Pettinger M; Prentice RL
    Clin Trials; 2007; 4(3):207-17. PubMed ID: 17715246
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The evidence provided by a single trial is less reliable than its statistical analysis suggests.
    Borm GF; Lemmers O; Fransen J; Donders R
    J Clin Epidemiol; 2009 Jul; 62(7):711-715.e1. PubMed ID: 19171462
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Incorporating intermediate binary responses into interim analyses of clinical trials: a comparison of four methods.
    Whitehead A; Sooriyarachchi MR; Whitehead J; Bolland K
    Stat Med; 2008 May; 27(10):1646-66. PubMed ID: 17886243
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A new 'mechanistic-practical" framework for designing and interpreting randomized trials.
    Karanicolas PJ; Montori VM; Devereaux PJ; Schünemann H; Guyatt GH
    J Clin Epidemiol; 2009 May; 62(5):479-84. PubMed ID: 18468856
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Clinical trials with drugs: the influence of the authorization process].
    Carcas AJ; Serrano MA; Avendaño C; Galende I; Tristán C; García-Alonso F
    Med Clin (Barc); 1995 May; 104(18):683-8. PubMed ID: 7769877
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Recent progress of clinical trials in urologic oncology].
    Hinotsu S
    Gan To Kagaku Ryoho; 2006 Feb; 33(2):188-92. PubMed ID: 16484854
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A step-by-step approach to the evaluation of clinical studies with therapeutic or preventive objectives.
    Vergara CM; Wang F
    Conn Med; 2003 Apr; 67(4):195-203. PubMed ID: 12760079
    [No Abstract]   [Full Text] [Related]  

  • 52. Comparing outcomes on peritoneal and hemodialysis: a case study in the interpretation of observational studies.
    Davies SJ
    Saudi J Kidney Dis Transpl; 2007 Mar; 18(1):24-30. PubMed ID: 17237887
    [No Abstract]   [Full Text] [Related]  

  • 53. The scientific basis of clinical trials: statistical aspects.
    Gehan EA
    Clin Cancer Res; 1997 Dec; 3(12 Pt 2):2587-90. PubMed ID: 9815661
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Critical analysis of a parallel group randomized trial].
    Giraudeau B
    Rev Pneumol Clin; 2002 Nov; 58(5 Pt 1):261-7. PubMed ID: 12486375
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Adding more muscle and nerve to clinical trials.
    Conwit RA; Bhanushali MJ; Porter JD; Kaufmann P; Gutmann L
    Muscle Nerve; 2011 Nov; 44(5):695-702. PubMed ID: 22006684
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Randomization as a basis for inference in noninferiority trials.
    Wiens BL
    Pharm Stat; 2006; 5(4):265-71. PubMed ID: 17128425
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Guidelines for clinical trials in melasma. Pigmentation Disorders Academy.
    Pandya A; Berneburg M; Ortonne JP; Picardo M
    Br J Dermatol; 2006 Dec; 156 Suppl 1():21-8. PubMed ID: 17176301
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Design of randomized controlled trials.
    Stanley K
    Circulation; 2007 Mar; 115(9):1164-9. PubMed ID: 17339574
    [No Abstract]   [Full Text] [Related]  

  • 59. Bayesian statistical inference enhances the interpretation of contemporary randomized controlled trials.
    Wijeysundera DN; Austin PC; Hux JE; Beattie WS; Laupacis A
    J Clin Epidemiol; 2009 Jan; 62(1):13-21.e5. PubMed ID: 18947971
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Design and conduct issues in surgical clinical trials.
    Neumayer L
    Am J Surg; 2004 Dec; 188(6A Suppl):17S-21S. PubMed ID: 15610888
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 32.